Synthesis, Characterization, Antimicrobial Activity and Molecular Docking of a Dinuclear Nickel(II) Complex

Main Article Content

Reem M. A. Ebrahim
Nehad M. Abdul Aziz
Yousif Sulfab
Nahla Omer
Elmugdad A. Ali
Emadeldin H. E. Konozy

Abstract

Bis-(benzidinedioxime) nickel(II) acetate complex was synthesizedby reacting  the metal ions with benzidinedioxime in 1:1 mole ratio.The nickel(II) complex was characterized by elemental analysis, NMR, and powder X-ray diffraction. The result obtained from CHN Elemental analysis and 1H nuclear magnetic resonance confirmed that the nickel(II) complex is synthesized by reacting benzidinedioxime with nickel(II) acetate in a 1:1 mole ratio. The powder XRD showed that two Ni(II) coordinated to two benzidinedioxime ligands via the nitrogen atoms of both oxime groups and the two azomethine nitrogen atoms. Powder X-ray diffraction (PXRD) indicated that the nickel(II) complex has little distorted tetrahedral geometry. Nickel(II) complex has a higher antimicrobial activist against K. pneumonia, B. subtilis, and Candida than kanamycin. In addition, the B. subtilis shows resistance against kanamycin (inhibition zone 0) while it shows high sensitivity against bis-benzidinedioxime nickel(II) acetate complex (inhibition zone 33.3 ± 0.82 mm, MIC 18.5 µg/mL). The average MICs of bis-benzidinedioxime nickel(II) acetate are found to be for inhibition of each of the five organisms in the range of 6.2–55.65 µg/mL. The molecular docking studies investigations confirmed that the bis-benzidinedioxime nickel(II) acetate is the most potent aminoglycoside enzymes bacterial inhibitors. The bis-benzidinedioxime nickel(II) acetate exhibited high binding energy with the receptor aminoglycoside-3-phosphotransferase enzyme than receptors of other aminoglycoside enzymes families.

Article Details

How to Cite
Reem M. A. Ebrahim, Nehad M. Abdul Aziz, Yousif Sulfab, Nahla Omer, Elmugdad A. Ali, & Emadeldin H. E. Konozy. (2022). Synthesis, Characterization, Antimicrobial Activity and Molecular Docking of a Dinuclear Nickel(II) Complex. International Journal of Medical Science and Clinical Research Studies, 2(08), 739–746. https://doi.org/10.47191/ijmscrs/v2-i8-04
Section
Articles

References

I. Gull, P. and A.A. Hashmi, "Biological activity studies on metal complexes of macrocyclic schiff base ligand: synthesis and spectroscopic characterization". Journal of the Brazilian Chemical Society, 2015. 26: p. 1331-1337.

II. Islam, F., et al., "Synthesis, characterization, and antimicrobial activity studies of Ni (II) complex with pyridine as a ligand". Journal of Chemistry, 2015. 2015.

III. Valko, M., H. Morris, and M. Cronin, "Metals, toxicity and oxidative stress". Current medicinal chemistry, 2005. 12(10): p. 1161-1208.

IV. Abdulkarem, A.A., "Synthesis and antibacterial studies of metal complexes of Cu (II), Ni (II) and Co (II) with tetradentate ligand". Journal of Biophysical Chemistry, 2017. 8(02): p. 13.

V. Chohan, Z.H. and C.T. Supuran, "Metalloantibiotics: Synthesis, characterization and in-vitro antibacterial studies on cobalt (II), copper (II), nickel (II) and zinc (II) complexes with cloxacillin". Journal of Enzyme Inhibition and Medicinal Chemistry, 2006. 21(4): p. 441-448.

VI. Anacona, J., et al., "Synthesis, characterization and antibacterial activity of a tridentate Schiff base derived from cephalexin and 1, 6-hexanediamine and its transition metal complexes". Med Chem, 2016. 6: p. 467.

VII. Gwaram, N.S., et al., "Antibacterial evaluation of some Schiff bases derived from 2-acetylpyridine and their metal complexes". Molecules, 2012. 17(5): p. 5952-5971.

VIII. Kumar, S., D.N. Dhar, and P. Saxena, "Applications of metal complexes of Schiff bases-A review". 2009.

IX. El‐Sonbati, A., et al., "Synthesis, characterization of Schiff base metal complexes and their biological investigation". Applied Organometallic Chemistry, 2019. 33(9): p. e5048.

X. Geeta, B., et al., "Binuclear cobalt(II), nickel(II), copper(II) and palladium(II) complexes of a new Schiff-base as ligand: synthesis, structural characterization, and antibacterial activity". Spectrochim Acta A Mol Biomol Spectrosc, 2010. 77(4): p. 911-5.

XI. Tedim, J., et al., Third‐Order Nonlinear Optical Properties of DA‐salen‐Type Nickel (II) and Copper (II) Complexes. 2006, WILEY‐VCH Verlag Weinheim.

XII. Demeshko, S., et al., "Targeted construction of azido-bridged Ni 4 complexes with decisive effect of µ-1, 3-azide torsion on the spin ground state". Dalton Transactions, 2006(28): p. 3458-3465.

XIII. Chaudhuri, P., et al., "Ferromagnetic vs. antiferromagnetic coupling in bis (µ 2-1, 1-azido) dinickel (ii) complexes with syn-and anti-conformations of the end-on azide bridges". Dalton Transactions, 2006(41): p. 4962-4968.

XIV. Rotthaus, O., et al., "Valence Tautomerism in Octahedral and Square‐Planar Phenoxyl–Nickel (II) Complexes: Are Imino Nitrogen Atoms Good Friends?". Chemistry–A European Journal, 2006. 12(26): p. 6953-6962.

XV. Sarkar, S., et al., "Synthesis, structure and magnetic properties of two end-on double azido bridged nickel (II) dinuclear entities incorporating N, N, N-coordinating tridentate reduced Schiff base ligands". Polyhedron, 2006. 25(1): p. 25-30.

XVI. Abdel-Rahman, L.H., et al., "Synthesis, physicochemical studies, embryos toxicity and DNA interaction of some new Iron (II) Schiff base amino acid complexes". Journal of Molecular Structure, 2013. 1040: p. 9-18.

XVII. Kumar, G., et al., "Synthesis, spectral characterization and antimicrobial evaluation of Schiff base Cr (III), Mn (III) and Fe (III) macrocyclic complexes". European journal of medicinal chemistry, 2012. 52: p. 269-274.

XVIII. Neelakantan, M., et al., "Spectral characterization, cyclic voltammetry, morphology, biological activities and DNA cleaving studies of amino acid Schiff base metal (II) complexes". Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2008. 71(4): p. 1599-1609.

XIX. Abu-Dief, A.M. and I.M. Mohamed, "A review on application of transition metal complexes incorporating Schiff bases". 2015.

XX. Lade, H. and J.-S. Kim, "Bacterial Targets of Antibiotics in Methicillin-Resistant Staphylococcus aureus". Antibiotics, 2021. 10(4): p. 398.

XXI. Worthington, R.J. and C. Melander, "Overcoming resistance to β-lactam antibiotics". The Journal of organic chemistry, 2013. 78(9): p. 4207-4213.

XXII. DAVIES, J., L. GORINI, and B.D. DAVIS, "Misreading of RNA codewords induced by aminoglycoside antibiotics". Molecular pharmacology, 1965. 1(1): p. 93-106.

XXIII. Moazed, D. and H.F. Noller, "Interaction of antibiotics with functional sites in 16S ribosomal RNA". Nature, 1987. 327(6121): p. 389-394.

XXIV. François, B., et al., "Crystal structures of complexes between aminoglycosides and decoding A site oligonucleotides: role of the number of rings and positive charges in the specific binding leading to miscoding". Nucleic acids research, 2005. 33(17): p. 5677-5690.

XXV. Nurizzo, D., et al., "The crystal structure of aminoglycoside-3′-phosphotransferase-IIa, an enzyme responsible for antibiotic resistance". Journal of molecular biology, 2003. 327(2): p. 491-506.

XXVI. Krause, K.M., et al., "Aminoglycosides: an overview". Cold Spring Harbor perspectives in medicine, 2016. 6(6): p. a027029.

XXVII. Landman, D., et al., "Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York City". Journal of antimicrobial chemotherapy, 2010. 65(10): p. 2123-2127.

XXVIII. Davies, J. and G.D. Wright, "Bacterial resistance to aminoglycoside antibiotics". Trends in microbiology, 1997. 5(6): p. 234-240.

XXIX. Rusthoven, J.J., T.A. Davies, and S.A. Lerner, "Clinical isolation and characterization of aminoglycoside-resistant small colony variants of Enterobacter aerogenes". The American journal of medicine, 1979. 67(4): p. 702-706.

XXX. Garza-Cervantes, J.A., et al., "Re-sensitizing ampicillin and kanamycin-resistant E. coli and S. aureus using synergistic metal micronutrients-antibiotic combinations". Frontiers in bioengineering and biotechnology, 2020: p. 612.

XXXI. Evans, A. and K.A. Kavanagh, "Evaluation of metal-based antimicrobial compounds for the treatment of bacterial pathogens". Journal of Medical Microbiology, 2021. 70(5).

XXXII. Frei, A., et al., "Metal complexes as a promising source for new antibiotics". Chemical science, 2020. 11(10): p. 2627-2639.

XXXIII. Nasiri Sovari, S. and F. Zobi, "Recent studies on the antimicrobial activity of transition metal complexes of groups 6–12". Chemistry, 2020. 2(2): p. 418-452.

XXXIV. Ebrahim, R.M.A., et al., "Synthesis, Characterization and PXRD Crystal Structure of Benzidinedioxime".

XXXV. Seeley, H. and P. Van Denmark, "A laboratory manual of microbiology". Taraporewala Sons and Co., Mumbai, 1975. 55.

XXXVI. Akitt, J.W. and B.E. Mann, NMR and Chemistry: An introduction to modern NMR spectroscopy. 2017: Crc Press.

XXXVII. Jacobsen, N.E., NMR spectroscopy explained: simplified theory, applications and examples for organic chemistry and structural biology. 2007: John Wiley & Sons.

XXXVIII. Abdel-Rahman, L.H., et al., "Design, characterization, teratogenicity testing, antibacterial, antifungal and DNA interaction of few high spin Fe(II) Schiff base amino acid complexes". Spectrochim Acta A Mol Biomol Spectrosc, 2013. 111: p. 266-76.

XXXIX. Neelakantan, M., et al., "Spectral, XRD, SEM and biological activities of transition metal complexes of polydentate ligands containing thiazole moiety". Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2008. 71(2): p. 628-635.

XL. Chohan, Z.H. and M. Praveen, "Synthesis, characterization, coordination and antibacterial properties of novel asymmetric 1, 1′‐disubstituted ferrocene‐derived Schiff‐base ligands and their Co (II), Cu (II) Ni (II) and Zn (II) complexes". Applied organometallic chemistry, 2001. 15(7): p. 617-625.

XLI. Chohan, Z.H. and M. Praveen, "Synthesis, characterization and antibacterial properties of symmetric 1, 1′‐ferrocene derived Schiff‐base ligands and their Co (II), Cu (II), Ni (II) and Zn (II) chelates". Applied organometallic chemistry, 2000. 14(7): p. 376-382.